190 related articles for article (PubMed ID: 30055232)
1. An incretin-based tri-agonist promotes superior insulin secretion from murine pancreatic islets via PLC activation.
Khajavi N; Finan B; Kluth O; Müller TD; Mergler S; Schulz A; Kleinau G; Scheerer P; Schürmann A; Gudermann T; Tschöp MH; Krude H; DiMarchi RD; Biebermann H
Cell Signal; 2018 Nov; 51():13-22. PubMed ID: 30055232
[TBL] [Abstract][Full Text] [Related]
2. A role of PLC/PKC-dependent pathway in GLP-1-stimulated insulin secretion.
Shigeto M; Cha CY; Rorsman P; Kaku K
J Mol Med (Berl); 2017 Apr; 95(4):361-368. PubMed ID: 28097390
[TBL] [Abstract][Full Text] [Related]
3. Progesterone receptor membrane component 1 is a functional part of the glucagon-like peptide-1 (GLP-1) receptor complex in pancreatic β cells.
Zhang M; Robitaille M; Showalter AD; Huang X; Liu Y; Bhattacharjee A; Willard FS; Han J; Froese S; Wei L; Gaisano HY; Angers S; Sloop KW; Dai FF; Wheeler MB
Mol Cell Proteomics; 2014 Nov; 13(11):3049-62. PubMed ID: 25044020
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice.
Lamont BJ; Li Y; Kwan E; Brown TJ; Gaisano H; Drucker DJ
J Clin Invest; 2012 Jan; 122(1):388-402. PubMed ID: 22182839
[TBL] [Abstract][Full Text] [Related]
5. Positive Allosteric Modulation of the Glucagon-like Peptide-1 Receptor by Diverse Electrophiles.
Bueno AB; Showalter AD; Wainscott DB; Stutsman C; Marín A; Ficorilli J; Cabrera O; Willard FS; Sloop KW
J Biol Chem; 2016 May; 291(20):10700-15. PubMed ID: 26975372
[TBL] [Abstract][Full Text] [Related]
6. Role of Epac2A/Rap1 signaling in interplay between incretin and sulfonylurea in insulin secretion.
Takahashi H; Shibasaki T; Park JH; Hidaka S; Takahashi T; Ono A; Song DK; Seino S
Diabetes; 2015 Apr; 64(4):1262-72. PubMed ID: 25315008
[TBL] [Abstract][Full Text] [Related]
7. Geniposide acutely stimulates insulin secretion in pancreatic β-cells by regulating GLP-1 receptor/cAMP signaling and ion channels.
Zhang Y; Ding Y; Zhong X; Guo Q; Wang H; Gao J; Bai T; Ren L; Guo Y; Jiao X; Liu Y
Mol Cell Endocrinol; 2016 Jul; 430():89-96. PubMed ID: 27126219
[TBL] [Abstract][Full Text] [Related]
8. New insights concerning the glucose-dependent insulin secretagogue action of glucagon-like peptide-1 in pancreatic beta-cells.
Holz GG
Horm Metab Res; 2004; 36(11-12):787-94. PubMed ID: 15655710
[TBL] [Abstract][Full Text] [Related]
9. Acute but not chronic activation of brain glucagon-like peptide-1 receptors enhances glucose-stimulated insulin secretion in mice.
Tudurí E; Beiroa D; Porteiro B; López M; Diéguez C; Nogueiras R
Diabetes Obes Metab; 2015 Aug; 17(8):789-99. PubMed ID: 25962313
[TBL] [Abstract][Full Text] [Related]
10. Activation of PPARβ/δ protects pancreatic β cells from palmitate-induced apoptosis by upregulating the expression of GLP-1 receptor.
Yang Y; Tong Y; Gong M; Lu Y; Wang C; Zhou M; Yang Q; Mao T; Tong N
Cell Signal; 2014 Feb; 26(2):268-78. PubMed ID: 24269940
[TBL] [Abstract][Full Text] [Related]
11. SUMO downregulates GLP-1-stimulated cAMP generation and insulin secretion.
Rajan S; Torres J; Thompson MS; Philipson LH
Am J Physiol Endocrinol Metab; 2012 Mar; 302(6):E714-23. PubMed ID: 22234371
[TBL] [Abstract][Full Text] [Related]
12. Feedback activation of phospholipase C via intracellular mobilization and store-operated influx of Ca2+ in insulin-secreting beta-cells.
Thore S; Dyachok O; Gylfe E; Tengholm A
J Cell Sci; 2005 Oct; 118(Pt 19):4463-71. PubMed ID: 16159958
[TBL] [Abstract][Full Text] [Related]
13. Glucagon Potentiates Insulin Secretion Via β-Cell GCGR at Physiological Concentrations of Glucose.
Zhang Y; Han C; Zhu W; Yang G; Peng X; Mehta S; Zhang J; Chen L; Liu Y
Cells; 2021 Sep; 10(9):. PubMed ID: 34572144
[TBL] [Abstract][Full Text] [Related]
14. Comparison of independent and combined effects of the neurotensin receptor agonist, JMV-449, and incretin mimetics on pancreatic islet function, glucose homeostasis and appetite control.
Craig SL; Gault VA; Shiels CE; Hamscher G; Irwin N
Biochim Biophys Acta Gen Subj; 2021 Aug; 1865(8):129917. PubMed ID: 33964357
[TBL] [Abstract][Full Text] [Related]
15. [Theoretical Investigations into the Quantitative Mechanisms Underlying the Regulation of [cAMP]i, Membrane Excitability and [Ca(2+)]i during GLP-1 Stimulation in Pancreatic β Cells].
Takeda Y
Yakugaku Zasshi; 2016; 136(3):467-71. PubMed ID: 26935088
[TBL] [Abstract][Full Text] [Related]
16. Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells.
Lee YS; Jun HS
Metabolism; 2014 Jan; 63(1):9-19. PubMed ID: 24140094
[TBL] [Abstract][Full Text] [Related]
17. Glucagon-like peptide 1 potentiates glucotoxicity-diminished insulin secretion via stimulation of cAMP-PKA signaling in INS-1E cells and mouse islets.
Luo G; Kong X; Lu L; Xu X; Wang H; Ma X
Int J Biochem Cell Biol; 2013 Feb; 45(2):483-90. PubMed ID: 23220045
[TBL] [Abstract][Full Text] [Related]
18. Coixol amplifies glucose-stimulated insulin secretion via cAMP mediated signaling pathway.
Hameed A; Hafizur RM; Khan MI; Jawed A; Wang H; Zhao M; Matsunaga K; Izumi T; Siddiqui S; Khan F; Adhikari A; Sharma KR
Eur J Pharmacol; 2019 Sep; 858():172514. PubMed ID: 31265841
[TBL] [Abstract][Full Text] [Related]
19. Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors.
Nauck M
Diabetes Obes Metab; 2016 Mar; 18(3):203-16. PubMed ID: 26489970
[TBL] [Abstract][Full Text] [Related]
20. The glucagon-like peptide-1 receptor agonist oxyntomodulin enhances beta-cell function but does not inhibit gastric emptying in mice.
Maida A; Lovshin JA; Baggio LL; Drucker DJ
Endocrinology; 2008 Nov; 149(11):5670-8. PubMed ID: 18669601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
